Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (91)
Bias in meta-analysis detected by a simple, graphical test
1997 • 47,526 citations
Meta-analysis in clinical trials
1986 • 36,193 citations
Operating Characteristics of a Rank Correlation Test for Publication Bias
1994 • 15,160 citations
Tumor Angiogenesis: Therapeutic Implications
1971 • 9,898 citations
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 • 5,595 citations
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
1998 • 4,679 citations
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 • 3,248 citations
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 • 2,891 citations
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 • 2,782 citations
Transplacental Carcinogenesis by Stilbestrol
1971 • 2,595 citations
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 • 2,548 citations
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 • 2,481 citations
VEGF and the quest for tumour angiogenesis factors
2002 • 1,467 citations
Epidemiology of Lung Cancer
2010 • 1,094 citations
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
2005 • 1,025 citations
Publication Bias: A Problem in Interpreting Medical Data
1988 • 773 citations
Epidemiology of Lung Cancer*
2003 • 733 citations
Epidemiology of Lung Cancer
2007 • 621 citations
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2004 • 602 citations
Small Cell Lung Cancer
2008 • 450 citations
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
2001 • 409 citations
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
1995 • 396 citations
Vascular Endothelial Cell Growth Factor Receptor 3–Mediated Activation of Lymphatic Endothelium Is Crucial for Tumor Cell Entry and Spread via Lymphatic Vessels
2005 • 393 citations
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
1997 • 305 citations
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
1998 • 275 citations
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
2000 • 275 citations
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
2002 • 267 citations
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
2004 • 265 citations
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002 • 237 citations
Contour-Enhanced Funnel Plots for Meta-Analysis
2008 • 225 citations
Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer
1997 • 223 citations
Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer
2000 • 217 citations
Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer
2004 • 192 citations
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
1998 • 175 citations
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
2003 • 163 citations
Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer
2005 • 162 citations
Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer
2006 • 160 citations
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
2003 • 160 citations
Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
2002 • 151 citations
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
2000 • 146 citations
Small cell lung carcinoma (SCLC): the angiogenic phenomenon
2002 • 136 citations
Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis
2005 • 135 citations
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
2002 • 133 citations
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
1998 • 132 citations
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
1997 • 131 citations
The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients
2001 • 123 citations
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature
2003 • 112 citations
Increased vascular endothelial growth factor and vascular endothelial growth factor–c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage i non–small cell lung cancer
2000 • 107 citations
Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer
2007 • 105 citations
The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer.
2002 • 97 citations
Clinical application of biological markers for treatments of resectable non-small-cell lung cancers
2005 • 97 citations
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
1998 • 96 citations
Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer
2000 • 95 citations
Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
1998 • 94 citations
Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
2001 • 87 citations
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients
2004 • 83 citations
The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients
2008 • 81 citations
Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer.
1998 • 80 citations
Total cyclooxygenase‐2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non‐small cell lung cancer patients
2005 • 76 citations
Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung
2002 • 73 citations
Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC
2004 • 70 citations
Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma.
1997 • 70 citations
Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients
2002 • 69 citations
Role of Serum Vascular Endothelial Growth Factor in the Prediction of Angiogenesis and Prognosis for Non-small Cell Lung Cancer
2005 • 67 citations
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis].
2002 • 65 citations
Clinical significance of vascular endothelial growth factor‐C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma
2005 • 62 citations
Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer
2001 • 60 citations
The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers.
2000 • 60 citations
Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography
2009 • 58 citations
Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
2006 • 58 citations
The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures
2008 • 58 citations
Correlation of angiogenesis with 18F‐FMT and 18F‐FDG uptake in non‐small cell lung cancer
2009 • 55 citations
VEGF et survie des patients atteints d'un cancer pulmonaire. Revue systématique avec méta-analyse.
2002 • 55 citations
Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis
2001 • 52 citations
CALGB 30306: A phase II study of cisplatin (C), irinotecan (I) and bevacizumab (B) for untreated extensive stage small cell lung cancer (ES-SCLC)
2007 • 50 citations
Immunohistochemical Analysis of Non-Small Cell Lung Cancer: Correlation with Clinical Parameters and Prognosis
2007 • 48 citations
Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung
2006 • 43 citations
Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung
2004 • 43 citations
A phase II study of cisplatin (P) plus etoposide (E) plus bevacizumab (B) for previously untreated extensive stage small cell lung cancer (SCLC) (E3501): A trial of the Eastern Cooperative Oncology Group
2007 • 39 citations
Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
2007 • 37 citations
Cell binding isoforms of vascular endothelial growth factor-A (VEGF189) contribute to blood flow-distant metastasis of pulmonary adenocarcinoma
2005 • 35 citations
Vascular Endothelial Growth Factor Level as a Prognostic Determinant of Small Cell Lung Cancer in Japanese Patients
2005 • 33 citations
Survival in small cell lung cancer is independent of tumor expression of VEGF and COX-2.
2004 • 32 citations
Squamous Cell Carcinoma Related Oncogene Regulates Angiogenesis through Vascular Endothelial Growth Factor-A
2004 • 25 citations
Vascular Endothelial Growth Factor Immunostaining Correlates with Postoperative Relapse and Survival in Non-Small Cell Lung Cancer
2007 • 18 citations
Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non‐small cell lung cancer
2004 • 17 citations
Predicting recurrence following curative surgery in stage I non-small cell lung cancer patients using an angiogenesis-associated factor.
2007 • 14 citations
Vascular endothelial growth factor expression in pN2 non‐small cell lung cancer: Lack of prognostic value
2005 • 13 citations
Prognostic value of vascular endothelial growth factor expression in primary lung carcinoma.
2000 • 11 citations
The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer
2006 • 9 citations
[Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
2003 • 5 citations